Cilostazol
Brand:
NICE TA: 223
Indication: Peripheral arterial disease (NICE TA223)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No
Background
LMMG is adopting the local decision made prior to April 2013
Recommendation
LMMG recommendation: Black
Click here to find the definitions for the colour classifications
Reason for decision: Not recommended for prescribing on the NHS in Lancashire
Supporting documents:
Decisions of Lancashire local decision making groups:
| NHS Blackburn With Darwen CCG and NHS East Lancashire CCG | NHS Blackpool CCG | NHS Chorley and South Ribble CCG and NHS Greater Preston CCG | NHS Fylde and Wyre CCG | NHS Morecambe Bay CCG | NHS West Lancashire CCG |
|---|---|---|---|---|---|
Black |
Black |
Black |
Black |
Black |
Black |
